Brett Mitchell is an experienced corporate finance executive with over 25 years of experience in the venture capital and equity capital markets, leading transactions in the mining, energy, technology and life sciences sectors. He has been involved in the founding, financing and management of both private and publicly-listed companies, including recently as a director of […]
Our Team
Dr. Paul Grint
Dr. Grint was most recently CEO and a member of the board of directors of AmpliPhi Biosciences which recently merged with C3J Therapeutics to form Armata Pharmaceuticals. Dr. Grint has more than two decades of experience in biologics and small molecule research and development, including the successful approval and commercialization of products in the infectious […]
Melanie Leydin CA FGIA
Melanie Leydin holds a Bachelor of Business majoring in Accounting and Corporate Law. Ms. Leydin is a member of the Institute of Chartered Accountants, Fellow of the Governance Institute of Australia, and is a Registered Company Auditor. Ms. Leydin graduated from Swinburne University in 1997, became a Chartered Accountant in 1999 and from February 2000 […]
Ward Detwiler
Ward Detwiler has spent his career focused on entrepreneurial leadership and the commercialization of advanced healthcare technology from concept to market. Most recently, Detwiler was the co-founder and CEO of SpinTech MRI, a medical imaging software company focused on reducing MRI exam times and bringing advanced quantitative imaging tools into clinical practice. As CEO, Detwiler […]
Robert Proulx
Bob has served as Chairman of the Board at Imagion Biosystems since the company’s IPO in 2017. As President and CEO of Imagion Biosystems beginning in February 2015 until June 2023, he led the company developing the nanoparticle-based medical imaging technology from early proof of concept through initial clinical development until June 2023. Bob’s career […]